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Translationally controlled tumor protein (TCTP) is a highly conserved protein found in eukaryotes, across animal and plant
kingdoms and even in yeast. Mammalian TCTP is ubiquitously expressed in various tissues and cell types. TCTP is a
multifunctional protein which plays important roles in a number of cell physiological events, such as immune responses, cell
proliferation, tumorigenicity, and cell death, including apoptosis. Recent identiﬁcation of TCTP as an antiapoptotic protein
has attracted interest of many researchers in the ﬁeld. The mechanism of antiapoptotic activity, however, has not been solved
completely, and TCTP might inhibit other types of cell death. Cell death (including apoptosis) is closely linked to proliferation and
tumorigenesis. In this context, we review recent ﬁndings regarding the role of TCTP in cell death, proliferation, and tumorigenesis
and discuss the mechanisms.
1.Introduction
Translationally controlled tumor protein (TCTP) was
initially identiﬁed as a factor implicated in cell growth
[1, 2]. TCTP has also been termed histamine releasing
factor (HRF), fortilin, P21, P23, TPT-1, and Q23. This
protein was named TCTP because its mRNA was controlled
at the translational level [3–5]. Although TCTP is found
ubiquitously in tissues and cell types, its expression is
relatively low in lung and colon, and cell lines derived
from normal cells such as a mouse ﬁbroblast NIH-3T3 and
human embryonic kidney HEK293T cells [6]. Because of its
multifunctional properties, TCTP has attracted the attention
of an increasing number of researchers in many ﬁelds
(reviewed in [7]). TCTP plays important roles in a number
of cell physiological events in cancer, cell proliferation, stress
response, gene regulation, and heat shock response [8–13].
TCTP was also shown to possess an extracellular function,
that is, histamine release [14].
Tumorigenicity, proliferation, and cell death, including
apoptosis, are closely related functions. Uncontrolled or
promoted proliferation and loss of cell death are general
properties of tumor cells. In this paper, we will focus on
mammalian TCTP and discuss its physiological functions,
emphasizing cell death, proliferation, and tumorigenesis.
2. Properties of TCTP
Human [5] and murine [3] TCTP cDNAs were isolated
and their sequences determined more than 20 years ago.
Human TCTP cDNA encodes a protein with a calculated
molecular mass of 19kDa (172 amino acids). Sequence
analyses revealed that TCTP is a highly conserved protein
lacking homology to any other protein. TCTP has been
found in a wide range of eukaryotes, including yeast,
plants, and animals, suggesting it originated in the distant
evolutionary past. Since immune systems are restricted to
animals, its function in histamine release has been acquired
only recently in evolution. Ubiquitous expression of TCTP
in mammalian tissues suggests its importance in normal
physiological functions. In fact, a gene-targeting approach2 Biochemistry Research International
revealed that TCTP is an essential protein in mice since
knockoutsdeﬁcientinthisproteindieatembryonicstageday
E9.5-E10.5 [15]. However, studies with mouse embryonic
ﬁbroblast (MEF) cells showed that TCTP is not essential
for cell survival in vitro [15]. The intracellular localization
of TCTP is predominantly in the cytosol and nucleus
[16] although it functions as an antiapoptotic protein in
mitochondria. TCTP is a hydrophilic protein and does
not contain any hydrophobic transmembrane domains or
any localization signals to an organelle [6]. Translocation
of TCTP to the nucleus under certain conditions such as
oxidative stress was reported recently. However, TCTP does
not contain a nuclear localization signal and the mechanism
of translocation remains to be solved [17].
3. TCTP InteractswithMany Kinds of Proteins
To exert various physiological functions, TCTP interacts
with many other proteins, including translation elongation
factors eEF1A and eEF-B-β [18], tubulin [19], actin [20],
myeloid cell leukemia protein-1 (MCL1) [6, 16], Bcl-xL
[21], p53 [22], and Na, K-ATPase [12]. TCTP can also bind
to itself, forming homodimers [11], and this binding is
required for the cytokine-like activity of this protein during
allergic responses [23]. However, it is not known whetherthe
dimerization of TCTP is necessary for its other functions.
4 .H o wDoe sT C T PP r o t ec tC ell sf r o mDeat h ?
It is well known that TCTP protects cells from death.
Although many mechanisms have been proposed, details
remain to be identiﬁed.
4.1. TCTP Could Directly Reduce Cellular Stress. TCTP
expression increases in response to a variety of cell stresses
and stimuli, and in some cases, TCTP could directly reduce
stress, protecting cells from death (Figure 1). The ﬁrst case
we describe deals with its protection of cells from heat
shock-induced cell death. TCTP is markedly upregulated in
a variety of cells following thermal shock. Recent studies
demonstrated that TCTP is a heat shock protein and
serves as a molecular chaperone. TCTP binds to denatured
proteins,refoldsthem,andalsointeractswithnativeproteins
and protects them from denaturation [24]. Although no
strong homology with other proteins has been found, recent
studies revealed relationships with guanine nucleotide-free
chaperones, the Mss4/Dss4 family of proteins that binds to
the GDP/GTP-free form of Rab [25]. This fact also supports
TCTP’s function as a chaperone.
ThesecondcaseiscelldeathinducedbyaninﬂuxofCa2+.
Thelevel of TCTPis controlledbytheintracellularCa2+ con-
centration and elevation of Ca2+ also induces TCTP mRNA
in cells [26]. Binding of TCTP to Ca2+ was demonstrated for
theﬁrsttimeusingTrypanosomabruceiprotein[27]andlater
with the human protein [28]. Thapsigargin raises cytosolic
Ca2+ by blocking the ability of the cells to pump calcium
into the ER, which depletes its Ca2+ stores. This depletion
cansecondarilyactivateplasmamembranecalciumchannels,
allowing an inﬂux of Ca2+ into the cytosol, thereby initiating
apoptosis. The lack of TCTP resulted in exaggerated eleva-
tion of Ca2+ in thapsigargin-challenged cells [29]. Elevation
of the intracellular Ca2+ level beyond the normal range
could injure mitochondrial membranes and lead to release
of cytochrome C and AIF, resulting in apoptosis. Graidist’s
group also demonstrated that Ca2+ binding of TCTP is
required for protection of the cells against thapsigargin-
induced apoptosis. They hypothesized that TCTP exerts its
antiapoptoticfunctionbyservingasaCa2+ scavenger.Onthe
other hand, thapsigargin is also known to induce ER stress,
in which unfolded proteins are accumulated in the organelle.
Thapsigargin reduces Ca2+ concentration in the ER and
suppresses small molecule Ca2+-dependent chaperones in
the organelle, allowing accumulation of aberrant proteins,
which in turn eventually leads cells to undergo apoptosis.
Thus, TCTP might also protect cells from ER stress-induced
apoptosis by inhibiting the signal pathway.
The last case is oxidative stress. TCTP from the parasite
Brugia malayi has antioxidant functions and when it was
overexpressed in Escherichia coli, it protected the cells from
hydrogen peroxide-induced cell death [30]. Although TCTP
used in this experiment originated in the parasite and was
expressed in bacteria, this result suggests that TCTP itself
might serve as antioxidant and could neutralize ROS in
mammalian cells.
4.2. TCTP Inhibits Apoptosis. Many types of cellular stresses
induce apoptosis via the mitochondrial pathway and TCTP
is able to inhibit this type of apoptosis by regulating the
relevantsignalpathways(Figure 1).TCTPprotectscellsfrom
apoptosis triggered by serum deprivation [6], or treatment
with etoposide, taxol, or 5-ﬂuorouracil [21, 31]. Mito-
chondria contain proapoptotic proteins such as apoptosis
inducing factor (AIF), Smac/DIABLO, and cytochrome C.
In the course of apoptosis, these proteins are released
from mitochondria following the formation of the perme-
ability transition pore in the membrane by the action of
proapoptotic Bcl-2 family proteins such as Bax and BH3.
Other Bcl-2 family members such as Bcl-2, MCL1, and
Bcl-xL are known to suppress apoptosis by binding and
inactivating the proapoptotic proteins. Among Bcl-2 family
proteins, MCL1 is a unique protein. Unlike other Bcl-2
family proteins, MCL1 is not constitutively expressed and
is induced by various stimuli. It was demonstrated that
TCTP speciﬁcally associates with MCL1 [8, 16], which has
the ability to stabilize TCTP [16]. In contrast to this result,
another research group showed that TCTP stabilized MCL1
by suppressing its degradation by blocking its ubiquitination
[8]. In their experimental conditions, MCL1 did not stabilize
TCTP. The discrepancies of the results obtained from the
two research groups are presumably due to the use of
diﬀerent cell lines and experimental conditions. TCTP and
MCL1 are also capable of functioning as antiapoptotic
proteins independently of each other [31]. Bcl-xL is another
antiapoptotic Bcl-2 family protein that interacts with TCTP.
In this case, binding between the BH3 domain of Bcl-
xL and the N-terminal region of TCTP is required forBiochemistry Research International 3
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Figure 1: TCTP protects cells from cell death. TCTP inhibits cell death induced by oxidative stress, heat shock, or inﬂux of Ca2+. In addition,
TCTP can protect cells from apoptosis triggered by treatment with genotoxic reagent such as etoposide and 5-ﬂuorouracil. TCTP inhibits
apoptosis by stabilizing antiapoptotic Bcl-2 family proteins, MCL1 and Bcl-xL and by inhibiting activation of proapoptotic Bcl-2 family
protein, Bax. Moreover, TCTP inhibits p53-dependent apoptosis by downregulating the protein.
the antiapoptotic activity of TCTP [8]. The BH3 domain
is responsible for hetero- and homodimerization between
antiapoptotic and proapoptotic Bcl-2 family proteins. TCTP
also interferes with dimerization of the proapoptotic Bcl-2
family protein Bax [32]. The crystal structure of TCTP was
solved and a structural similarity with that of Bax [32]w a s
found despite lack of amino acid sequence homology. This
similarity suggests localization of TCTP to mitochondrial
membranes.DimerizationofBaxisrequiredforitsapoptotic
activity and TCTP blocks the formation of Bax homodimers
by inserting into mitochondrial membranes (reviewed in
[33]). Although TCTP inhibits apoptosis induced by Bax,
unlike MCL1 and Bcl-xL, TCTP does not bind Bax directly.
TCTP aﬀects the tumor suppressor p53 (Figures 1 and
2) .T h em u t a t i o ni np 5 3i sf o u n di na b o u th a l fo fa l lc a n c e r s
and dysfunction of the protein is one of the main causes
of cancer development. p53 is also a potent mediator of
cellular responses against various cellular stresses including
genotoxic insults. In addition, overexpression of p53 induces
apoptosis in cancer cells. TCTP was shown to bind p53 and
prevent apoptosis by destabilizing the protein in a human
lungcarcinomacelllineA549[22].TCTPalsorepressestran-
scription of p53 [34]. These facts also indicate the ability of
TCTP to promote transformation by reducing p53 function.
4.3. Oxidative Stress-Induced Cell Death and TCTP. Intrinsic
reactive oxygen species (ROS) such as hydrogen peroxide,
superoxide,andhydroxylradicalsaregeneratedincellsinthe
course of normal metabolism, including electron transport
and various oxidase reactions. Oxidative stress induced by
ROShasbeenimplicatedinagingandinthepathophysiology
of various diseases such as diabetes, cancer, and Parkinson’s
disease (reviewed in [35]). These diseases are, at least in part,
caused by ROS-mediated cell death in tissues. Although the
eﬀect of TCTP on apoptosis ﬁrst attracted attention, TCTP
might regulate other types of cell death. The types of cell
death induced by oxidative stress depend on the cell lines
and experimental conditions. In most cases, however, cell
death caused by oxidative stress leads to necrosis rather than
apoptosis. Types of hydrogen peroxide-induced cell death
diﬀer depending on cell types, and conditions of hydrogen
peroxide treatment and cell culture. High concentrations
of hydrogen peroxide inhibited apoptosis in T-lymphoma
Jurkat cells by lowering intracellular ATP levels (necessary
for apoptosome formation), and this might also be the
case in other cell lines [36]. In the course of isolating
cDNAs which protect cells from hydrogen peroxide, we
found for the ﬁrst time that TCTP could inhibit cell death
induced by oxidative stress [37]. Overexpression of TCTP
protected hydrogen peroxide-induced cell death in a Chinese
hamsterovarycellline,CHO-K1;however,celldeathwasnot
typical apoptosis. Although the cells showed apoptosis-like
morphological changes after hydrogen peroxide treatment,
their genomic DNA did not show DNA ladder pattern
formation [37]. Presumably the cells stopped apoptotic
signaling after cytochrome C release from mitochondria and4 Biochemistry Research International
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Figure 2: TCTP functions as an oncogene. NUMB forms a tricomplex with p53 and the E3 ubiquitin ligase MDM2, thereby preventing
ubiquitination followed by degradation of p53. TCTP promotes p53 degradation by competing with NUMB for MDM2 binding. TCTP
binds to Na, K-ATPase and, as a result, it releases Src binding to Na, K-ATPase and activate it. TCTP can release coﬁlin binding to G-actin by
competing with and replacing coﬁlin. The increase of free coﬁlin then promotes the binding of the protein to F-actin and exerts its functions.
were subjected to secondary necrosis. Recent studies showed
the existence of programmed necrosis (necroptosis) which
is physiological cell death regulated by its signal pathway
(reviewed in [38]). TCTP might inhibit the signal pathways
of physiologically regulated necrosis. As mentioned in the
previous section, it is also possible that TCTP itself acts as an
antioxidantandreducesoxidativestressinducedbyhydrogen
peroxide. This protective eﬀect of TCTP against oxidative
stress is presumably an intrinsic function in malignant breast
cancer cells. Treatment with hydrogen peroxide upregulated
TCTP level in T4-2 malignant breast cancer cells, but not
in their parental S-1 cells that are nonmalignant [39]. TCTP
upregulation was also observed in another breast cancer cell
line, MDB-MB-231 after treatment with hydrogen peroxide
or arsenic trioxide [40], which leads to ROS generation.
In conclusion, oxidative stress upregulates cellular TCTP
levels leading to cellular protection against death. However,
hydrogen peroxide treatment did not upregulate TCTP in
another tumorigenic cell line (CHO-K1), although over-
expression of TCTP protects cells from hydrogen peroxide
[37]. The mechanisms by which oxidative stress upregulates
TCTP are not known. Interestingly, TCTP translocates from
cytosol to the nucleus in a keratinocyte cell line (HaCat)
where it binds the vitamin D3 receptor [17]. Thus far, the
physiological meaning of TCTP binding to the vitamin D3
receptor is not clear. However, this interesting phenomenon
suggests that TCTP might regulate transcription of genes in
response to oxidative stress. As the upregulation mediated
by hydrogen peroxide is restricted to malignant cancer cells,
protein factors controlling its expression could be suitable
targets for cancer drug discovery. Primary culture cells of
mouse embryonic ﬁbroblasts (MEF) from TCTP knockout
and control mice manifested similar proliferative activities
and apoptotic sensitivities to various stimuli including
hydrogen peroxide treatment [15]. These results suggest that
prevention of cell death by TCTP is restricted to certain
cell types such as transformed cancer cells. This hypothesis
was supported by the fact that the depletion of TCTP by
siRNA induced apoptosis via caspases 8 and 3 in human
prostate cancer cell line LNCaP [41] .I n t e r e s t i n g l y ,M m i 1 P ,a
yeastorthologofmammalianTCTPthatbindsmicrotubules,
translocatesfromthecytosoltomitochondriafollowingmild
oxidative stress stimuli. In contrast to its mammalian coun-
terpart, Mmi P has an apoptotic function in yeast cells [42].
5. Tumorigenicity andTCTP
Several lines of evidence indicate that TCTP can induce
oncogenic transformation. Transformation of normal cells
into tumor cells requires a series of genetic changes. Since
TCTP is overexpressed in many types of cancer cells and
silencing of the gene decreases the viability of the cells [6], it
waspostulatedthatTCTPfunctionsasanoncogene.Tuynder
et al. developed unique systems to select cells with a reverted
phenotype using H-1 parvovirus which preferentially kills
tumor cells [19, 43]. TCTP was found to be downregulated
in reverted cells with a normal phenotype. In addition,
silencing of TCTP with antisense DNA or siRNA revealed
a reverted tumor phenotype, supporting this idea [19, 43,
44]. These results suggest that TCTP is directly involved
in malignant transformation. Although the mechanisms of
TCTP-dependent transformation are not known, it could be
the result of p53 destabilization as noted in the previous
section. Another line of evidence also indicates regulation
of p53 by TCTP and vice versa. NUMB is a protein known
to be a regulator of p53. It forms a tricomplex with p53Biochemistry Research International 5
and the E3 ubiquitin ligase MDM2, thereby preventing
ubiquitination followed by degradation of p53 [45]. TCTP
promotes p53 degradation by competing with NUMB for
MDM2 binding (Figure 2). On the other hand, p53 directly
represses transcription of TCTP. Thus, TCTP and p53 form
a reciprocal negative regulation loop [34]. This fact also
suggests that TCTP might inhibit p53-dependent apoptosis
by downregulating the protein.
The most important properties of tumor and cancer
cells are unregulated cell proliferation and avoidance of
cell death. Inhibition or gene silencing by TCTP siRNA
reduces viability and induces apoptosis in cancer cells,
including human prostate cancer cells [41]. TCTP might
also be involved in the malignancy of tumors by interacting
with actin at the coﬁlin binding site. Coﬁlin is an actin
binding protein and has the ability to regulate the cell cycle
(reviewed in [46]) and promote metastasis [47]. TCTP
competes with coﬁlin at the coﬁlin-binding site of actin.
Although coﬁlin can bind to both monomeric (G-actin)
and ﬁlamentous actin (F-actin), it exerts its functions by
binding to and changing the twist of F-actin. On the other
hand, TCTP has a higher aﬃnity with G-actin than F-actin.
TCTP can release coﬁlin binding to G-actin by competing
with and replacing coﬁlin. The increase of free coﬁlin then
promotes the binding of the protein to F-actin and exerts its
functions (Figure 2)[ 20]. Recent studies also revealed that
TCTP induces transformation in human breast epithelial
cells through activation of a protooncogene product Src
[48]. TCTP binds to the α1 subunit of Na, K-ATPase and,
as a result, it releases Src binding to Na, K-ATPase. This
TCTP-mediated Src release activates Src and promotes
various tumor progression signal pathways (Figure 2)[ 48].
6. TCTP Regulates CellProliferation
Since TCTP is highly expressed in actively dividing cells
[28, 49], one might expect TCTP to modulate physiological
functions during cell proliferation. TCTP has the ability to
bind microtubules during G1-, S-, G2-, and M-phases of
the cell cycle. It associates with the metaphase spindle, but
is detached from the spindle after metaphase [50]. TCTP is
phosphorylated by the polo-like kinase Plk, which is likely
to cause detachment of TCTP from the mitotic spindle [9].
Since the TCTP level is upregulated during entry into the cell
cycle, the protein is believed to be important for cell growth
and division. TCTP overexpression in mammalian cells
results in cell cycle retardation, microtubule stabilization,
and alteration of cell morphology [49]. Furthermore, TCTP
mutated in the phosphorylation sites for Plk disrupts the
completion of mitosis, indicating the importance of TCTP
phosphorylation in normal cell cycle regulation [9]. The
fact that increased TCTP levels slow cell cycle progression
is unexpected because high levels of TCTP expression
are generally observed in actively dividing cells and the
discrepancy has yet to be explained.
TCTP might regulate proliferation through the target of
rapamycin (TOR) pathway. TOR is a Ser/Thr kinase that reg-
ulates proliferation and metabolism in response to nutrients,
hormones, and growth factors. In case of Drosophila, Dor-
sophila TCTP (dTCTP) binds to nucleotide free form of a
small GTPase, Drosophila Ras homolog enriched in brain
(dRheb), and stimulates GDP-GTP exchange of dRheb. As a
result, dTCTP activates the TOR signaling pathways. In fact,
tissue-speciﬁc reduction of dTCTP in vivo resulted in smaller
organs with reduction of both cell size and cell number [51].
This might be also the case in mammals [52].
7. Concluding Remarks
We have reviewed recent ﬁndings on biological eﬀects of
mammalian TCTP, focusing on inhibition of cell death, reg-
ulation of proliferation, and tumorigenesis. Although many
hypotheses have been proposed, mechanistic explanations of
TCTP on phenomena are still elusive. Presumably, TCTP is
abletomodulatemultipleproteintargetssimultaneouslyand
asaresult,itexertseﬀects.Furthercomprehensivestudiesare
necessary to clarify the detailed mechanisms. Recent studies
also suggest protective functions of TCTP against cell death
other than apoptosis. The mechanisms of TCTP’s action on
the cell death is interesting and important issues in future
studies.
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